Needham & Company LLC reiterated their buy rating on shares of Harmony Biosciences (NASDAQ:HRMY – Free Report) in a research report released on Wednesday morning, Benzinga reports. Needham & Company LLC currently has a $52.00 price objective on the stock. A number of other research analysts have also recently commented on HRMY. Citigroup started coverage […]

Needham & Company LLC reaffirmed their buy rating on shares of Harmony Biosciences (NASDAQ:HRMY – Free Report) in a research note published on Wednesday, Benzinga reports. They currently have a $52.00 price target on the stock. A number of other equities analysts have also recently weighed in on the company. UBS Group started coverage on […]

Trane Technologies (NYSE:TT – Free Report) had its price target raised by Barclays from $394.00 to $425.00 in a research note released on Wednesday morning, Benzinga reports. The firm currently has an overweight rating on the stock. TT has been the topic of several other research reports. Morgan Stanley began coverage on shares of Trane […]

Needham & Company LLC reaffirmed their buy rating on shares of Magnite (NASDAQ:MGNI – Free Report) in a report released on Wednesday, Benzinga reports. The firm currently has a $15.00 target price on the stock. A number of other research analysts also recently weighed in on the company. Wolfe Research initiated coverage on Magnite in […]